Roledumab
From WikiMD's WELLNESSPEDIA
| Roledumab | |
|---|---|
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | 1174008-79-7 |
| PubChem | |
| DrugBank | |
| ChemSpider | none |
| KEGG | |
Roledumab is a monoclonal antibody. It binds to RHD, the Rhesus factor antigen.[1]
It is currently at Phase III trials for Rh disease.
References[edit]
- ↑ World Health Organization."International Nonproprietary Names for Pharmaceutical Substances (INN). Proposed INN: List 103".WHO Drug Information.2010;Full text.
 | This medical article is a stub. You can help WikiMD by expanding the page. |
